These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30462989)

  • 1. Kv4.3 expression abrogates and reverses norepinephrine-induced myocyte hypertrophy by CaMKII inhibition.
    Wang Y; Keskanokwong T; Cheng J
    J Mol Cell Cardiol; 2019 Jan; 126():77-85. PubMed ID: 30462989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of Kv4.3 gene reverses cardiac remodeling and transient-outward K
    Tao B; Liu Z; Wei F; Fan S; Cui S; Xia H; Xu L
    Biomed Pharmacother; 2020 Dec; 132():110896. PubMed ID: 33254430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of Kv4.2 and Kv4.3 channels by calmodulin-dependent protein kinase II in rat cardiac myocytes.
    Colinas O; Gallego M; Setién R; López-López JR; Pérez-García MT; Casis O
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1978-87. PubMed ID: 16648177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
    MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
    Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kv4 potassium channels form a tripartite complex with the anchoring protein SAP97 and CaMKII in cardiac myocytes.
    El-Haou S; Balse E; Neyroud N; Dilanian G; Gavillet B; Abriel H; Coulombe A; Jeromin A; Hatem SN
    Circ Res; 2009 Mar; 104(6):758-69. PubMed ID: 19213956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
    Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
    Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaMKII Modulates the Cardiac Transient Outward K
    Alday A; Ahyayauch H; Fernández-López V; Echeazarra L; Urrutia J; Casis O; Gallego M
    Cell Physiol Biochem; 2020 Jan; 54(1):27-39. PubMed ID: 31935048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes.
    Xiao L; Coutu P; Villeneuve LR; Tadevosyan A; Maguy A; Le Bouter S; Allen BG; Nattel S
    Circ Res; 2008 Sep; 103(7):733-42. PubMed ID: 18723449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Kv4.3-CaMKII unit in heart: an intrinsic negative regulator for CaMKII activation.
    Keskanokwong T; Lim HJ; Zhang P; Cheng J; Xu L; Lai D; Wang Y
    Eur Heart J; 2011 Feb; 32(3):305-15. PubMed ID: 21148163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolae-specific activation loop between CaMKII and L-type Ca
    Tonegawa K; Otsuka W; Kumagai S; Matsunami S; Hayamizu N; Tanaka S; Moriwaki K; Obana M; Maeda M; Asahi M; Kiyonari H; Fujio Y; Nakayama H
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H501-H514. PubMed ID: 28039202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CaMKII phosphorylation site Thr1604 in the Ca
    Li J; Wang S; Zhang J; Liu Y; Zheng X; Ding F; Sun X; Zhao M; Hao L
    Channels (Austin); 2020 Dec; 14(1):151-162. PubMed ID: 32290730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis.
    Lebeche D; Kaprielian R; del Monte F; Tomaselli G; Gwathmey JK; Schwartz A; Hajjar RJ
    Circulation; 2004 Nov; 110(22):3435-43. PubMed ID: 15557376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin modulates remodeling of Kv4.3 expression in rat hypertrophied cardiomyocytes.
    Su F; Shi M; Yan Z; Ou D; Li J; Lu Z; Zheng Q
    Int J Biol Sci; 2012; 8(2):236-48. PubMed ID: 22253567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes.
    Zobel C; Kassiri Z; Nguyen TT; Meng Y; Backx PH
    Circulation; 2002 Oct; 106(18):2385-91. PubMed ID: 12403671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of action potential duration on myocyte hypertrophic pathways.
    Lebeche D; Kaprielian R; Hajjar R
    J Mol Cell Cardiol; 2006 May; 40(5):725-35. PubMed ID: 16600293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed endosome-dependent CamKII and p38 kinase signaling in cardiomyocytes destabilizes Kv4.3 mRNA.
    Zhou C; Cavolo SL; Levitan ES
    J Mol Cell Cardiol; 2012 May; 52(5):971-7. PubMed ID: 22266351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib activates pathological hypertrophy by altering myocyte calcium regulation.
    Barr LA; Makarewich CA; Berretta RM; Gao H; Troupes CD; Woitek F; Recchia F; Kubo H; Force T; Houser SR
    Clin Transl Sci; 2014 Oct; 7(5):360-7. PubMed ID: 24931551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urotensin II induction of neonatal cardiomyocyte hypertrophy involves the CaMKII/PLN/SERCA 2a signaling pathway.
    Shi H; Han Q; Xu J; Liu W; Chu T; Zhao L
    Gene; 2016 May; 583(1):8-14. PubMed ID: 26930364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Kv4 potassium channel modulator NS5806 attenuates cardiac hypertrophy in vivo and in vitro.
    Cai Y; Zhang J; Zhang H; Qi J; Shi C; Xu Y
    Sci Rep; 2024 Aug; 14(1):19839. PubMed ID: 39191928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.